Loading...
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease.
Lamarca, Angela Benafif, S Ross, P Bridgewater, J
Lamarca, Angela
Benafif, S
Ross, P
Bridgewater, J
Citations
Altmetric:
Abstract
The advanced biliary tract cancer (ABC)-02 study established cisplatin and gemcitabine (CisGem) as a reference 1(st)-line regimen for patients with advanced/metastatic biliary tract cancer; patients with bilirubin ⩾1.5 × upper limit of normal (ULN) were excluded and there are few extant data for systemic treatment in the context of elevated bilirubin.
Description
Date
2015-06-08
Publisher
Collections
Keywords
Type
Article
Citation
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease. 2015: Eur J Cancer